T&R Biofab Co., Ltd.
246710.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$104.86B
Close$
Share Statistics
| Market cap | $104.86 Billion |
|---|---|
| Enterprise Value | $129.36 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-759.93 |
| Beta | 0.46 |
| Outstanding Shares | 47,660,256 |
Return
| Return on Equity | -144.81% |
|---|---|
| Return on Assets | -33.10% |
| Return on Invested Capital | -18.37% |
Valuation & Multiples
| P/E Ratio | -2.75 |
|---|---|
| PEG | 23.22 |
| Price to Sales | 3.01 |
| Price to Book Ratio | 4.65 |
| Enterprise Value to Revenue | 3.95 |
| Enterprise Value to EBIT | -18.19 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 1.44 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About T&R Biofab Co., Ltd.
82 employees
CEO: Wonsoo Yun T&R Biofab Co., Ltd. is dedicated to advancing medical technology through the development of innovative devices designed for tissue regeneration and transplantation procedures. Their work primarily serves the fields of orthopedics, plast...